Stock Watch: US Election Brings More Cons Than Pros For Life Sciences
Biotech Initially Outperforms Pharma, But Both Eventually Succumb
The US election result brought stock market volatility especially to pharma and biotech companies but the poster children for approved GLP-1 agonists and vaccines were initially the hardest hit.
